Skip to main content
Clinical Trials/NCT02936934
NCT02936934UnknownPhase 4

Comparison of Adverse Drug Reactions Associated for Oxycodone and Morphine in Postoperative Pain After Abdominal Hysterectomy

Hospital Civil de Guadalajara0 sites64 target enrollmentStarted: October 2016Last updated:
Conditions
Interventions
Drugs

Trial Snapshot

Phase
Phase 4
Enrollment
64
Primary Endpoint
Adverse drug reactions (questionnaire)

Study Overview

Brief Summary

The objective of this study is compare adverse reactions associated with oxycodone and morphine for the treatment of postoperative pain after abdominal hysterectomy

Detailed Description

A randomized single-blind study, was performed to compare the adverse reactions associated with oxycodone and morphine in patients undergoing abdominal hysterectomy.

process:

  1. A clinical history of patients candidates to participate in the study will be developed.
  2. If you meet the selection criteria will be held the invitation to participate in the study, reading the letter under information

Patients who agree to participate in the study will be managet during the surgical procedure:

15 mg mixed blockade with bupivacaine 0.5% + 25 micrograms of fentanyl 10mg / kg intravenously during surgery metamizol 3) After the surgical procedure (immediate postoperative)

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Single (Participant)

Eligibility Criteria

Ages
30 Years to 55 Years (Adult)
Sex
Female
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • Patients scheduled for abdominal hysterectomy
  • Signing for informed consent

Exclusion Criteria

  • Patients used with MAO inhibitor drugs (<14 days before surgery)
  • History of substance abuse
  • Hypersensitivity to opioids and others drugs of multimodal analgesia (metamizol and lidocaine)
  • Pretreatment of any opioid (<7/2 lives of the drug in question)
  • Chronic pain of any etiology (> 6 months)
  • Diagnosis of bowel obstruction
  • Renal or hepatic insufficiency
  • Asthma, chronic obstructive pulmonary disease (COPD), and/ or hypothyroidism.
  • Patients requiring general anesthesia for surgical complications

Arms & Interventions

Morphine

Active Comparator

Multimodal analgesia to morphine

Intervention: Morphine (Drug)

Oxycodone

Experimental

Multimodal analgesia to oxycodone

Intervention: Oxycodone (Drug)

Outcomes

Primary Outcomes

Adverse drug reactions (questionnaire)

Time Frame: 24 hours

Nausea, vomiting, respiratory depression, dizziness, headache, sedation, pruritus and anaphylaxis

Secondary Outcomes

  • systemic blood pressure (mmHg) (physiological parameter)(24 hours)
  • Postoperative pain (Numeric Pain Rating Scale)(24 hours)
  • Heart rate (physiological parameter)(24 hours)
  • Oxygen saturation (physiological parameter)(24 hours)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

VIRGINIA ALEYDA SANCHEZ LOPEZ

MD Pharmacology

Hospital Civil de Guadalajara

Similar Trials